BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17401010)

  • 1. Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemia.
    Hess CJ; Berkhof J; Denkers F; Ossenkoppele GJ; Schouten JP; Oudejans JJ; Waisfisz Q; Schuurhuis GJ
    J Clin Oncol; 2007 Apr; 25(10):1209-15. PubMed ID: 17401010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative receptor tyrosine kinases and anti-apoptotic transcripts hold potential for predicting inferior outcome in adult acute myeloid leukemia: a prospective pilot study.
    Sharawat SK; Vishnubhatla S; Bakhshi R; Raina V; Kumar L; Sharma A; Bakhshi S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):501-508.e2. PubMed ID: 25065779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
    Kim HJ; Choi EJ; Sohn HJ; Park SH; Min WS; Kim TG
    Eur J Haematol; 2013 Nov; 91(5):411-22. PubMed ID: 23826993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
    Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
    Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
    Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
    Aref S; Salama O; Al-Tonbary Y; Mansour A
    Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coexpression of the apoptosis-related genes bcl-2 and wt1 in predicting survival in adult acute myeloid leukemia.
    Karakas T; Miething CC; Maurer U; Weidmann E; Ackermann H; Hoelzer D; Bergmann L
    Leukemia; 2002 May; 16(5):846-54. PubMed ID: 11986946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML).
    Köhler T; Schill C; Deininger MW; Krahl R; Borchert S; Hasenclever D; Leiblein S; Wagner O; Niederwieser D
    Leukemia; 2002 Jan; 16(1):22-9. PubMed ID: 11840259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.
    Mehta SV; Shukla SN; Vora HH
    Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
    Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of survivin and X-linked inhibitor of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML).
    Ibrahim AM; Mansour IM; Wilson MM; Mokhtar DA; Helal AM; Al Wakeel HM
    Lab Hematol; 2012 Mar; 18(1):1-10. PubMed ID: 22459568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of antiapoptotic gene aven in de novo acute myeloid leukemia patients and its clinical significance].
    Geng SX; DU X; Weng JY; Zhong LY; Guo R; Lu ZS; Chen ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1424-8. PubMed ID: 20030919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
    Huang TS; Myklebust LM; Kjarland E; Gjertsen BT; Pendino F; Bruserud Ø; Døskeland SO; Lillehaug JR
    Mol Cancer; 2007 Apr; 6():31. PubMed ID: 17451600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
    Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
    Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML.
    Sun SM; Rockova V; Bullinger L; Dijkstra MK; Döhner H; Löwenberg B; Jongen-Lavrencic M
    Leukemia; 2013 Jan; 27(1):100-6. PubMed ID: 22692398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ RHAMM protein expression in acute myeloid leukemia blasts suggests poor overall survival.
    Tzankov A; Strasser U; Dirnhofer S; Menter T; Arber C; Jotterand M; Rovo A; Tichelli A; Stauder R; Günthert U
    Ann Hematol; 2011 Aug; 90(8):901-9. PubMed ID: 21274712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
    Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
    Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 gene and its family genes Bax, Bcl-Xl as well as Fas/Apo-1 and their clinical significance in acute leukemia.
    Chen Y; Zhou J; Yue B; Xiang Z; Song X; Li C; Wang B
    Chin Med J (Engl); 1998 Aug; 111(8):682-5. PubMed ID: 11245018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.